Metropolitan Life Insurance CO Cara Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$2.83 - $4.94 $3,452 - $6,026
1,220 Added 95.99%
2,491 $7,000
Q1 2023

May 15, 2023
SELL
$4.89 - $12.27 $8,396 - $21,067
-1,717 Reduced 57.46%
1,271 $6,000
Q4 2022

Jun 14, 2023
BUY
$8.88 - $12.77 $15,246 - $21,926
1,717 Added 135.09%
2,988 $32.1 Million
Q3 2022

Jun 14, 2023
BUY
$8.24 - $12.56 $14,148 - $21,565
1,717 Added 135.09%
2,988 $28 Million
Q2 2022

Jun 20, 2023
BUY
$7.45 - $13.84 $12,791 - $23,763
1,717 Added 135.09%
2,988 $27,000
Q1 2022

Jun 20, 2023
BUY
$9.94 - $12.65 $17,066 - $21,720
1,717 Added 135.09%
2,988 $36,000
Q1 2022

Mar 30, 2023
SELL
$9.94 - $12.65 $91,030 - $115,848
-9,158 Reduced 75.4%
2,988 $36,000
Q1 2022

May 12, 2022
SELL
$9.94 - $12.65 $91,030 - $115,848
-9,158 Reduced 75.4%
2,988 $36,000
Q4 2021

Jun 21, 2023
BUY
$11.99 - $18.14 $130,391 - $197,272
10,875 Added 855.63%
12,146 $147,000
Q4 2021

Mar 30, 2023
SELL
$11.99 - $18.14 $14,148 - $21,405
-1,180 Reduced 8.85%
12,146 $147,000
Q4 2021

Feb 15, 2022
SELL
$11.99 - $18.14 $14,148 - $21,405
-1,180 Reduced 8.85%
12,146 $148,000
Q3 2021

Jun 21, 2023
BUY
$11.55 - $16.06 $139,235 - $193,603
12,055 Added 948.47%
13,326 $205,000
Q2 2021

Jun 21, 2023
BUY
$12.38 - $29.19 $149,240 - $351,885
12,055 Added 948.47%
13,326 $190,000
Q2 2021

Mar 30, 2023
BUY
$12.38 - $29.19 $5,942 - $14,011
480 Added 3.74%
13,326 $190,000
Q2 2021

Aug 16, 2021
BUY
$12.38 - $29.19 $164,814 - $388,606
13,313 Added 102407.69%
13,326 $190,000
Q1 2021

Jun 26, 2023
BUY
$15.07 - $21.71 $174,435 - $251,293
11,575 Added 910.7%
12,846 $279 Million
Q1 2021

May 14, 2021
SELL
$15.07 - $21.71 $193,393 - $278,604
-12,833 Reduced 99.9%
13 $279,000
Q4 2020

Jun 22, 2023
BUY
$12.72 - $16.16 $147,234 - $187,052
11,575 Added 910.7%
12,846 $194,000
Q3 2020

Jun 26, 2023
BUY
$12.34 - $17.92 $142,835 - $207,424
11,575 Added 910.7%
12,846 $163,000
Q2 2020

Jun 26, 2023
BUY
$12.39 - $17.33 $143,414 - $200,594
11,575 Added 910.7%
12,846 $219,000
Q1 2020

Jul 12, 2023
BUY
$9.12 - $17.78 $105,563 - $205,803
11,575 Added 910.7%
12,846 $169,000
Q1 2020

Mar 30, 2023
BUY
$9.12 - $17.78 $4,514 - $8,801
495 Added 4.01%
12,846 $169,000
Q1 2020

May 15, 2020
BUY
$9.12 - $17.78 $4,514 - $8,801
495 Added 4.01%
12,846 $170,000
Q4 2019

Jul 12, 2023
BUY
$16.11 - $25.98 $178,498 - $287,858
11,080 Added 871.75%
12,351 $198,000
Q4 2019

Mar 30, 2023
SELL
$16.11 - $25.98 $13,999 - $22,576
-869 Reduced 6.57%
12,351 $198,000
Q4 2019

Feb 14, 2020
SELL
$16.11 - $25.98 $13,999 - $22,576
-869 Reduced 6.57%
12,351 $199,000
Q3 2019

Jul 12, 2023
BUY
$18.28 - $26.91 $218,427 - $321,547
11,949 Added 940.13%
13,220 $241,000
Q3 2019

Mar 30, 2023
BUY
$18.28 - $26.91 $33,744 - $49,675
1,846 Added 16.23%
13,220 $241,000
Q3 2019

Nov 14, 2019
BUY
$18.28 - $26.91 $33,744 - $49,675
1,846 Added 16.23%
13,220 $242,000
Q2 2019

Jul 12, 2023
BUY
$17.68 - $21.57 $178,621 - $217,921
10,103 Added 794.89%
11,374 $244,000
Q1 2019

Jul 13, 2023
BUY
$14.41 - $19.64 $145,584 - $198,422
10,103 Added 794.89%
11,374 $223,000
Q1 2019

Mar 30, 2023
BUY
$14.41 - $19.64 $120,842 - $164,701
8,386 Added 280.66%
11,374 $223,000
Q1 2019

May 16, 2019
SELL
$14.41 - $19.64 $76,171 - $103,817
-5,286 Reduced 31.73%
11,374 $223,000
Q1 2019

May 15, 2019
BUY
$14.41 - $19.64 $76,171 - $103,817
5,286 Added 46.47%
16,660 $826,000
Q4 2018

Jul 13, 2023
BUY
$12.45 - $23.47 $125,782 - $237,117
10,103 Added 794.89%
11,374 $147,000
Q4 2018

Feb 14, 2019
BUY
$12.45 - $23.47 $141,606 - $266,947
11,374 New
11,374 $148,000
Q3 2018

Nov 14, 2018
SELL
$17.57 - $23.95 $152,595 - $208,005
-8,685 Closed
0 $0
Q4 2017

Feb 15, 2018
SELL
$11.86 - $14.08 $93,504 - $111,006
-7,884 Reduced 47.58%
8,685 $106,000
Q2 2017

Aug 14, 2017
BUY
N/A
16,569
16,569 $255,000

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $262M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email